This document provides definitions and principles related to pharmacology and pharmacotherapeutics. It defines key terms like pharmacology, pharmacotherapeutics, drug, and medicine. It describes the principles of pharmacology as how exogenously administered drugs interact with the living system, which depends on pharmacokinetics of how the body affects the drug and pharmacodynamics of how the drug affects the body. Principles of pharmacotherapeutics include applying pharmacological knowledge together with disease knowledge for diagnosis, prevention and treatment. Factors like age, sex, genetics, and route of administration can modify a drug's effects.
PH1.3 Enumerate and identify drug formulations and drug delivery systemsPKGupta8
Difference between dosage form & formulation
What is drug delivery & drug delivery systems?
Difference between conventional & newer drug delivery systems
Newer drug delivery systems, their advantages & disadvantages
Any question?
PH1.3 Enumerate and identify drug formulations and drug delivery systemsPKGupta8
Difference between dosage form & formulation
What is drug delivery & drug delivery systems?
Difference between conventional & newer drug delivery systems
Newer drug delivery systems, their advantages & disadvantages
Any question?
Anti anginal drugs, uses, mechanism of action, adverse effectsKarun Kumar
A presentation outlining the causes of angina, mechanism of action of various anti-anginal drugs, their uses and side effects alongwith contraindications
COMPUTER AIDED LEARNING-DESIGN-Simulation exercises for PHASE II pharmacology MBBS STUDENTS-MEDICAL COLLEGES-COMPETENCY BASED UNDERGRADUATE CURRICULUM-MCI-NMC-INDIAN MEDICAL GRADUATE TRAINING-OBJECT BASED ASSESSMENT-COMPETENCY PH4.2
Expt. 6 Bioassay of histamine using guinea pig ileum by matching methodVISHALJADHAV100
Objective
Principle
Requirements
Experimental specifications (conditions)
Preparation of histamine standard solution
Preparation of Tyrode solution (PSS)
Procedure
Kymograph recording of contractions
Observation table
Calculation
Result and interpretation
Anti anginal drugs, uses, mechanism of action, adverse effectsKarun Kumar
A presentation outlining the causes of angina, mechanism of action of various anti-anginal drugs, their uses and side effects alongwith contraindications
COMPUTER AIDED LEARNING-DESIGN-Simulation exercises for PHASE II pharmacology MBBS STUDENTS-MEDICAL COLLEGES-COMPETENCY BASED UNDERGRADUATE CURRICULUM-MCI-NMC-INDIAN MEDICAL GRADUATE TRAINING-OBJECT BASED ASSESSMENT-COMPETENCY PH4.2
Expt. 6 Bioassay of histamine using guinea pig ileum by matching methodVISHALJADHAV100
Objective
Principle
Requirements
Experimental specifications (conditions)
Preparation of histamine standard solution
Preparation of Tyrode solution (PSS)
Procedure
Kymograph recording of contractions
Observation table
Calculation
Result and interpretation
This Presentation is about Pharmacogenomics and Pharmacogenetics , its Working , application, History.
It also contain a little bit info related to polypharmacy and its effects.
You can also see information regarding Drug Metabolism Phase, and drug Metabolizing Enzymes like CYPs, VKORC1, TPMT
Pharmacogenomics is new science about how the systematic identification of all the human genes, their products, interindividual variation, intraindividual variation in expression and function over time affects drug response/metabolism, etc.
Improve drug safety and reduce ADRs. The presentation explained the advantages of pharmacogenomics. Explained Goals of Pharmacogen(etics)omics.
1.1 Pharmacology- An Introduction
The word pharmacology is derived from two Greek words, pharmacon meaning a drug, and logos meaning an opinion or reason. It can be defined as
“The science which deals with the history, source, physical properties, chemical properties, compounding, biochemical effects, physiological effects, mechanism of action, absorption, distribution, biotransformation, excretion, therapeutic and other uses of drugs, is called pharmacology.”
“The study of a substance that interacts with the living system through chemical processes especially by binding to regulatory molecules and activates or inhibits normal body processes”
“The science of substances used to prevent, diagnose and treat disease.”
Drug:
The word drug comes from Drogue meaning a dry herb. A drug can be defined as:
“A substance, material or product used for the purpose of diagnosis, prevention and relief of symptoms or cure of disease.”
WHO defines drug as:
“A substance, material or product used or intended to be used to modify or explore the physiological processes or pathological states for the benefit of the recipient.”
General Features of a Drug:
• Variability in molecular size
• Variability in shape
• Variability in chemical nature
• Variability in lipid/water partition coefficient
• Variability in degree of ionization
• Physical Properties
• Variability in molecular size
Smaller sized molecules are easily absorbed than larger molecules. Normally the molecular weight is between 100-1000 but may be higher or lower. Streptokinase is an example of large molecular weight drug while lithium or nitric oxides are of small molecular weight.
• Variability in shape
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
Letter to MREC - application to conduct studyAzreen Aj
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The global radiation oncology market size reached US$ 8.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.
More Info:- https://www.imarcgroup.com/radiation-oncology-market
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
4. Specific Learning Objectives of PH1.1
At the end of this theory session the phase II MBBS
student will be able to:
• Define terminology pharmacology,
• Define terminology pharmacotherapeutics,
• Describe the principles of pharmacology,
• Describe the principles of pharmacotherapeutics.
• Define Drug and various terminologies relevant in
Pharmacology course,
• Summarize expansion of pharmacology.
5. Pharmacology
Definition:
“It is the branch of science that deals with
interaction of exogenously administered
chemical molecules in the living system”.
Pharmakon – Drug, Logos - Study
6. What is a DRUG ?
• Drogue (French) – a dry herb
• Definition: WHO (1966)
– “Drug is any substance or product that is used
or intended to be used to modify or explore
a physiological system or a pathological
state for the benefit of the recipient”.
8. What is a Pharmacotherapeutics?
• Definition:
“Application of pharmacological
information together with the knowledge
of the disease for its diagnosis, prevention
and cure”.
9. • Describe the principles of pharmacology,
and / or
• Describe the principles of
pharmacotherapeutics.
10. To explain / understand easily about the principles
of pharmacology and the principles of
pharmacotherapeutics:-
• Any exogenously administered molecules
effects the physiological or pathological
states, either due to:
Living Body’s Factors:
Means
What the body does to
the drug?
Exogenously administered
drug factors:
Means
What the drug does to the
body?
12. Pharmacokinetics
• Kinesis (Greek) – movement
• Definition:
– This refers to “the movement of the drug in
the body, and the alterations of the drug by
the body through:
»Absorption
»Distribution
»Metabolism
»Excretion”.
13. Pharmacodynamics
• Dynamics (Greek) – power
Definition:
– “This refers to “the physiological and
biochemical effects of drugs and their
mechanisms of action at:
macromolecular
subcellular
organ system level”.
14. PHARMACOGENETICS :
Study of Genetic influences on responses to drugs.
• Examples :
(a) Fast Acetylation of INH is in Eskimos, Japanese.
(b) Slow Acetylation of INH is in Jews, Scandinavians,
North African Caucasians. the study of the
cost-effectiveness of drug treatments”.
(c) Primaquine induced hemolysis in G6PD deficient
individuals, occur in ~ 10% of black males in USA & in
some coloured Caucasian ethnic groups.
(d) Atypical pseudocholinesterase results in prolonged
succinylcholine apnoea.
15. • Pharmacotherapeutics:
– Application of pharmacological information
together with the knowledge of the disease
for its prevention and cure.
• Chemotherapy:
– Treatment of systemic infections /
malignancies with specific drugs that have
selective toxicity for the infecting organism
/ malignant cell, with no / minimal effects on
the host cell.
16. PHARMACOGENOMICS :
Use of genetic information to guide the choice of
drug therapy.
It is a branch of pharmacology, which deals with the study of heritable
variations in genes that determine the drug response in human beings,
microbes and tumors and explores the methods to use these
variations to predict the response of drug in a patient. This genome
based approach help to develop more specific (target) and safer drug
”. Exam.: Gefitinib is highly effective in curing lung cancer but only in
those patients who have mutations in the tyrosine kinase receptor
(10% of the cases), which is targeted action of this drug.
This branch overlaps pharmacogenetics.
17. Definition : Chronopharmacology
• “Study of drug effects which is based on
biological timing as well as its effects upon
circadian rhythm is called Chronopharmacology”.
• Examples :
(a) Peak effects of histamine-induced skin reaction to
intradermal injection or airway reactivity common at
midnight.
(b) Peak Ach-induced bronchial reaction occur mainly at
noon.
(c) Alteration in plasma glucose & growth hormone
circadian rhythm by insulin.
18. Definition : Placebo
• Latin = I please,
• “it is an inactive substance or preparation which
is used for its nonspecific, psychological or
psychophysiological effect on a patient, on
symptoms or on an illness.”
• Examples :
(a) Vitamin B1, B6 & B12 are used as placebo in absence of
vitamin deficiency.
Note: * Placebo may have some physiological effect, e.g.
release of endogenous opioids in the brain, b/k
naloxone can overcome placebo-induced analgesia.
* Placebo used mainly as a control in experimental studies.
19. PHARMACOEPIDEMIOLOGY :
Study of drug effects at the population level.
PHARMACOECONOMICS :
Branch of health economics, aims to quantify in
economic terms, the cost and benefit of drugs
used therapeutically.
BIOTECHNOLOGY:
Use of recombinant DNA Technology for
manufacturing therapeutic proteins, Diagnostics,
Genotyping etc.
20. Divisions in Pharmacology
• Clinical Pharmacy
– Evaluation of various formulations of drugs.
• Clinical Pharmacology
– Evaluation of drug action in humans.
• Experimental Pharmacology:
– Evaluation of drug action in animals.
• Communication Pharmacology:
- Evaluation of communication skills regarding the
drug’s require information deliver to the patient /
pharmacist.
21. Definition : Pharmacy
• “It is the art & science of compounding &
dispensing drugs or preparing suitable
dosage forms for administration of drugs in
man & animals. It includes collection,
identification, purification, isolation,
synthesis, standardization & quality control
of medicinal substances”.
22.
23. Definition : Toxicology
• “It is study of poisonous effect of drugs &
other chemicals (house-hold, environmental
pollutant, industrial, agricultural, homicidal)
with emphasis on detection, prevention &
treatment of poisonings”.
24. Describe the principles of pharmacology,
and / or
Describe the principles of pharmacotherapeutics.
1) Pharmacokinetics –
a. Absorption,
b. Bioavailability,
c. Storage,
d. Distribution,
e. Volume of Distribution,
f. Storage, Binding capacity
g. Metabolism,
h. Elimination.
i. Drug Dosing: Standard Dose, Regulated
Dose, Target Level Dose, Titrated Dose, etc.
2) Pharmacodynamics –
a. Ion channel mediated,
b. G Protein coupled protein
Receptors,
c. Tyrosine Protein Kinase
Receptor,
d. Nuclear Receptor
mediated.
e. Non-enzymatic mediated
action.
25. Describe the principles of pharmacology,
and / or
Describe the principles of pharmacotherapeutics.
3) Fixed Dose Combinations
(FDC) of Drugs:
Advantages: –
Better patience compliance,
synergistic drugs more effective,
more than two component of
therapeutic effects add up –
amlodipine + Atenolol,
Side effects counteract among
two drugs,
Multi-drugs therapy reduces drug
resistance.
Disadvantages:-
Unwanted FDC increases cost of the
therapy,
FDC difficult to individualize the dose,
Time course is different but in FDC it is
not applicable,
Individual component alter renal /
hepatic function differently,
Individual component Side effect difficult
to overcome,
Contraindication to one component
(allergy etc.) contraindicates the whole
component.
Confusion of therapeutic aims & false
sense of superiority of two drugs over
one is fostered.
26. Describe the principles of pharmacology,
and / or
Describe the principles of pharmacotherapeutics.
4) Factors modifying Drug Action:
i. Body Size:
• Average built person require standard
dose,
• Exceptionally obese, lean, and for children
need BSA to calculate accurate dose.
ii. Age:
• Premature newborn, mature newborn,
Infant, children: GFR is low, tubular
transport is immature and hepatic enzymes
inadequately developed.
• Elderly- Renal function, hepatic functions
declined progressively.
iii. Sex:
Females have smaller body size, thus
lower side dose range required than
average male.
Digoxin increases mortality in female
CHF more than male of CHF.
Clonidine, methyldopa, β-blockers,
diuretics interfere with sexual function in
males but not in females.
Ketoconazole, metoclopramide
chlorpromazine, digitalis, cause
gynaecomastia in male.
Ketoconazole cause loss of libido in
male but not in female.
27. Describe the principles of pharmacology,
and / or
Describe the principles of pharmacotherapeutics.
4) Factors modifying Drug Action:
During Pregnancy:
GIT motility is reduced – delay absorption,
Vd increased due to expansion of plasma
and ECF.
Risk of acidic drugs toxicity increases b/k
fall in albumin.
Risk of basic drug toxicity decreases.
Polar drugs eliminate faster – b/k increase
Renal blood flow.
Many drugs metabolized faster – b/k
hepatic microsomal enzymes undergo
induction.
iv. Species and Race:
• Rabbit resistant to atropine.
• Rat , mice are resistant to digitalis.
• Rat more sensitive to curare than Cat.
Blacks require higher and Mongols
require lower concentrations of atropine
and ephedrine to dilate their pupil.
β – blockers are less effective as
antihypertensive in Afro-Caribbeans.
Widespread use of chloramphenicol in
India and Hong Kong between 1950 –
1980, relatively few cases of aplastic
anaemia reported than the west.
v. Genetics:
Pharmacogenetics-
Pharmacogenomics
vi. Route of Drug Administration:
• governs speed and intensity of drug
response.
28. Describe the principles of pharmacology,
and / or
Describe the principles of pharmacotherapeutics.
4) Factors modifying Drug Action:
vii. Environmental factors and Time
of administration of drug:
• Rabbit resistant to atropine.
• Rat , mice are resistant to digitalis.
• Rat more sensitive to curare than Cat.
viii. Psychological Factors:
• Efficacy of drug can be affected by the
patient’s belief, attitudes and expectations.
• Placebo:
• Nocebo:
ix. Pathological states:
• GIT Diseases:
• Hepatic diseases:
Kidney Diseases:
CHF:
Thyroid Diseases:
X. Other Drug:
XI. Cumulation:
XII. Tolerance: Natural, Acquired, Cross
Tolerance.
• Acquired Tolerance:
• Cross Tolerance:
XIII. Tachyphylaxis:
XIV. Drug Resistance:
5) Pharmaceutical Factors: Particle
size, Salt form, Crystal form, Water of Hydration,
Nature of Excipients & Adjuvants, Degree of
Ionization.
29. A. Pharmaceutical Factors:
1. Particle size_
While ↓ing the particle size SURFACE AREA of
the particle will ↑d, thus absorption will be faster,
so bioavailability will be more.
Example: Microfined p/ps of Aspirin,
spironolactone, Griseofulvin, Digoxin, etc.
30. A. Pharmaceutical Factors:
2. Salt form
As a rule, salt of weakly acidic drugs are highly
soluble in water.
Free acidic drug is precipitated from these salts
in a microcrystalline form which has faster
dissolution rate and enhanced bioavailability.
Example: Tolbutamide sodium, Phenytoin sodium have
better bioavailability than tolbutamide & Phenytoin (as
free drugs).
31. A. Pharmaceutical Factors:
3. Crystal form
Amorphous form of the p/ps, like
chloramphenicol palmitate, amorphous
novobiocin have faster dissolution rate &
better bioavailability compared to their
crystalline forms.
32. A. Pharmaceutical Factors:
4. Water of Hydration
Many drugs can associate with water to
produce crystalline forms called the
HYDRATES.
The anhydrous forms of caffeine,
theophylline & ampicillin have faster
dissolution rate & better bioavailability
compared to their hydrous forms of these
drugs.
33. A. Pharmaceutical Factors:
5. Nature of Excipients & Adjuvants
These are pharmaceutical inert substances
(e.g., starch, lactose, calcium sulfate, gum,
polysorbate-80) which are added to the
formulation as a filling material to ↑d bulk of
the p/ps.
34. A. Pharmaceutical Factors:
6. Degree of Ionization
Nonionized lipid soluble drugs are better
absorbed, while
Strongly acidic or basic drugs or highly
ionized drugs show reduced bioavailability
from GIT, e.g. streptomycin, neostigmine, Ach
& its analogues, d-Tubocurarine.
35. B. Pharmacological & Physiological
Factors:
1. Gastric Emptying & GI. Motility,
2. Food & Other substances,
3. First – Pass Effect,
4. Drug – Drug Interactions,
5. Gastrointestinal diseases,
6. Pharmacogenetic Factors,
7. In addition, All other factors which
influence absorption of drugs.
37. Overall goal of the Pharmacology
The broad goal of the teaching of
pharmacology to the undergraduate
students in Pharmacology is to inculcate a
rational and scientific basis of
therapeutics.
38. A) KNOWLEDGE :
(1)Describe the pharmacokinetics and pharmacodynamics of essential
and commonly used drugs.
(2) List of indications, contraindications, interactions, and adverse
reactions of commonly used drugs:
(3) Indicate the use of appropriate drug in a particular disease with
consideration to its cost efficacy and safety for Individual needs
(5) Mass therapy under national health programmes.
(6) Describe the pharmacokinetic basis, clinical presentations.,
diagnosis and management of common poisonings.
39. (7) List the drug’s addiction and recommend the management.
(8) Classify environmental and occupational pollutants and state the
management issues.
(9) Indicate causation in prescription of drugs in special medical situations such
as pregnancy, lactation, infancy and old age.
(10) Integrate the concept of rational drug therapy in clinical pharmacology.
(11) State the principles underlying the concept of “Essential Drugs”.
(12) Evaluate the ethics and modalities in the development and introduction of
new drugs.
40. B) SKILLS :
(1) Prescribe drugs for common ailments.
(2) Recognize adverse reactions and interactions of commonly used drugs.
(3) Observe experiments designed for study of effects of drugs, bio-assay and
interpretation of the experimental data.
(4) Scan information on common pharmaceutical preparations and critically
evaluate drug formulations.
C) INTEGRATION :
• Practical knowledge of use of drugs in clinical practice will be acquired through
integrated teaching with clinical departments and pre-clinical departments.